Nu Skin Enterprises, Inc.
NUS NYSE Wholesale-Drugs, Proprietaries & Druggists' Sundries Financials FY2016–FY2025
Last close · Oct 23, 2026
$4.79
2.6%
Revenue
Total sales reported in the income statement.
$1.5B
14.3%
vs prior year
Operating margin
Operating income as a share of revenue.
4.4%
13.2 pts
Net income
Profit after all expenses, interest and tax.
$160M
Free cash flow
Cash from operations minus capital spending.
$46.0M
34.4%
Return on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
6.8%
20.9 pts
Market cap
Last close times the latest diluted share count, so it is approximate.
$233M
Oct 23 close
P/E
Last close divided by diluted earnings per share over the last four quarters.
—
On −$4.49 EPS (TTM)
What Nu Skin Enterprises, Inc. does
No business description yet.
- Legal name
- NU SKIN ENTERPRISES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 13, 2026
- Accession · CIK
- 0001140361-26-005130
0001021561
Revenue and margins
Nu Skin Enterprises, Inc. had $1.5B of revenue in fiscal 2025, down 14.3% on the year before.
FY16
Revenue $2.2B
FY17
Revenue $2.3B
FY18
Revenue $2.7B
FY19
Revenue $2.4B
FY20
Revenue $2.6B
FY21
Revenue $2.7B
FY22
Revenue $2.2B
FY23
Revenue $2.0B
FY24
Revenue $1.7B
FY25
Revenue $1.5B
Q3 '23
Revenue $499M
Q4 '23
Revenue $489M
Q1 '24
Revenue $417M
Q2 '24
Revenue $439M
Q3 '24
Revenue $430M
Q4 '24
Revenue $446M
Q1 '25
Revenue $364M
Q2 '25
Revenue $386M
Q3 '25
Revenue $364M
Q4 '25
Revenue $370M
Q1 '26
Revenue $321M
Q2 '26
Revenue $320M
FY16
Gross 77.3%
Operating 10.5%
Net 6.5%
FCF 10.2%
FY17
Gross 78.0%
Operating 12.0%
Net 5.7%
FCF 10.6%
FY18
Gross 76.3%
Operating 9.0%
Net 4.5%
FCF 4.9%
FY19
Gross 76.0%
Operating 11.0%
Net 7.2%
FCF 4.6%
FY20
Gross 74.5%
Operating 10.0%
Net 7.4%
FCF 12.2%
FY21
Gross 75.0%
Operating 8.7%
Net 5.5%
FCF 2.7%
FY22
Gross 71.7%
Operating 5.0%
Net 4.7%
FCF 2.2%
FY23
Gross 68.9%
Operating 2.5%
Net 0.4%
FCF 3.1%
FY24
Gross 68.2%
Operating −8.8%
Net −8.5%
FCF 4.1%
FY25
Gross 69.4%
Operating 4.4%
Net 10.8%
FCF 3.1%
Gross
Operating
Net
FCF
Q3 '23
Gross 58.6%
Operating −5.3%
Net −7.4%
FCF 7.8%
Q4 '23
Gross 72.1%
Operating 3.3%
Net 1.5%
FCF 6.9%
Q1 '24
Gross 70.5%
Operating 2.1%
Net −0.1%
FCF −2.1%
Q2 '24
Gross 70.0%
Operating −28.6%
Net −26.9%
FCF 9.8%
Q3 '24
Gross 70.1%
Operating 4.2%
Net 1.9%
FCF 5.3%
Q4 '24
Gross 62.7%
Operating −11.9%
Net −8.1%
FCF 3.0%
Q1 '25
Gross 67.8%
Operating −2.7%
Net 29.5%
FCF −3.6%
Q2 '25
Gross 68.8%
Operating 8.0%
Net 5.5%
FCF 9.3%
Q3 '25
Gross 70.5%
Operating 5.9%
Net 4.7%
FCF 4.8%
Q4 '25
Gross 70.7%
Operating 6.3%
Net 3.9%
FCF 1.6%
Q1 '26
Gross 66.9%
Operating 1.3%
Net 0.6%
FCF −5.5%
Q2 '26
Gross 68.2%
Operating −18.5%
Net −78.0%
FCF 1.6%
Gross
Operating
Net
FCF
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 2.5% a year. Loss periods are shown in red.
FY16
Net income $143M
FY17
Net income $129M
FY18
Net income $122M
FY19
Net income $174M
FY20
Net income $191M
FY21
Net income $147M
FY22
Net income $105M
FY23
Net income $8.6M
FY24
Net income −$147M
FY25
Net income $160M
Q3 '23
Net income −$37.0M
Q4 '23
Net income $7.3M
Q1 '24
Net income −$0.5M
Q2 '24
Net income −$118M
Q3 '24
Net income $8.3M
Q4 '24
Net income −$36.1M
Q1 '25
Net income $108M
Q2 '25
Net income $21.1M
Q3 '25
Net income $17.1M
Q4 '25
Net income $14.5M
Q1 '26
Net income $1.8M
Q2 '26
Net income −$250M
FY16
Diluted EPS $2.55
FY17
Diluted EPS $2.36
FY18
Diluted EPS $2.16
FY19
Diluted EPS $3.10
FY20
Diluted EPS $3.63
FY21
Diluted EPS $2.86
FY22
Diluted EPS $2.07
FY23
Diluted EPS $0.17
FY24
Diluted EPS −$2.95
FY25
Diluted EPS $3.18
Q3 '23
Diluted EPS −$0.74
Q4 '23
Diluted EPS $0.14
Q1 '24
Diluted EPS −$0.01
Q2 '24
Diluted EPS −$2.38
Q3 '24
Diluted EPS $0.17
Q4 '24
Diluted EPS −$0.73
Q1 '25
Diluted EPS $2.14
Q2 '25
Diluted EPS $0.43
Q3 '25
Diluted EPS $0.34
Q4 '25
Diluted EPS $0.27
Q1 '26
Diluted EPS $0.04
Q2 '26
Diluted EPS −$5.14
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
FY16
Return on capital 21.8%
Return on equity 21.5%
Return on assets 9.7%
FY17
Return on capital 27.2%
Return on equity 18.9%
Return on assets 8.4%
FY18
Return on capital 19.2%
Return on equity 16.4%
Return on assets 7.4%
FY19
Return on capital 20.4%
Return on equity 20.9%
Return on assets 10.0%
FY20
Return on capital 23.9%
Return on equity 21.6%
Return on assets 10.3%
FY21
Return on capital 16.3%
Return on equity 16.3%
Return on assets 7.6%
FY22
Return on capital 10.9%
Return on equity 11.6%
Return on assets 5.6%
FY23
Return on capital 3.0%
Return on equity 1.0%
Return on assets 0.5%
FY24
Return on capital −14.1%
Return on equity −19.9%
Return on assets −8.9%
FY25
Return on capital 6.8%
Return on equity 22.0%
Return on assets 11.1%
Return on capital
Return on equity
Return on assets
Cash flow
Free cash flow was $46.0M in fiscal 2025, 3.1% of revenue. Cash from operations minus capital spending.
FY16
Free cash flow $225M
FY17
Free cash flow $242M
FY18
Free cash flow $132M
FY19
Free cash flow $112M
FY20
Free cash flow $315M
FY21
Free cash flow $73.0M
FY22
Free cash flow $49.0M
FY23
Free cash flow $60.1M
FY24
Free cash flow $70.2M
FY25
Free cash flow $46.0M
Q3 '23
Free cash flow $39.1M
Q4 '23
Free cash flow $33.8M
Q1 '24
Free cash flow −$9.0M
Q2 '24
Free cash flow $43.1M
Q3 '24
Free cash flow $22.8M
Q4 '24
Free cash flow $13.2M
Q1 '25
Free cash flow −$13.2M
Q2 '25
Free cash flow $35.8M
Q3 '25
Free cash flow $17.6M
Q4 '25
Free cash flow $5.9M
Q1 '26
Free cash flow −$17.6M
Q2 '26
Free cash flow $5.0M
FY16
Cash from operations $275M
Capital spending $50.2M
FY17
Cash from operations $303M
Capital spending $60.2M
FY18
Cash from operations $203M
Capital spending $70.4M
FY19
Cash from operations $178M
Capital spending $66.1M
FY20
Cash from operations $379M
Capital spending $63.8M
FY21
Cash from operations $142M
Capital spending $68.6M
FY22
Cash from operations $108M
Capital spending $59.1M
FY23
Cash from operations $119M
Capital spending $58.5M
FY24
Cash from operations $112M
Capital spending $41.6M
FY25
Cash from operations $80.3M
Capital spending $34.3M
Cash from operations
Capital spending
Q3 '23
Cash from operations $51.0M
Capital spending $11.9M
Q4 '23
Cash from operations $54.2M
Capital spending $20.4M
Q1 '24
Cash from operations $3.3M
Capital spending $12.3M
Q2 '24
Cash from operations $51.2M
Capital spending $8.1M
Q3 '24
Cash from operations $31.4M
Capital spending $8.6M
Q4 '24
Cash from operations $25.8M
Capital spending $12.6M
Q1 '25
Cash from operations $0.4M
Capital spending $13.6M
Q2 '25
Cash from operations $35.8M
Capital spending $0.0M
Q3 '25
Cash from operations $27.5M
Capital spending $9.9M
Q4 '25
Cash from operations $16.6M
Capital spending $10.8M
Q1 '26
Cash from operations −$3.9M
Capital spending $13.7M
Q2 '26
Cash from operations $10.6M
Capital spending $5.6M
Cash from operations
Capital spending
Dividends, buybacks and share count
Nu Skin Enterprises, Inc. returned $31.9M to shareholders in fiscal 2025, 69% of free cash flow. The diluted share count rose 1.3%.
FY16
Dividends $78.4M
Buybacks $247M
FY17
Dividends $76.1M
Buybacks $71.7M
FY18
Dividends $80.6M
Buybacks $69.6M
FY19
Dividends $82.2M
Buybacks $0.8M
FY20
Dividends $78.4M
Buybacks $144M
FY21
Dividends $76.3M
Buybacks $80.4M
FY22
Dividends $77.0M
Buybacks $70.0M
FY23
Dividends $77.6M
Buybacks $13.0M
FY24
Dividends $11.9M
Buybacks $0.0M
FY25
Dividends $11.8M
Buybacks $20.0M
Dividends
Buybacks
Q3 '23
Dividends $19.5M
Buybacks $13.0M
Q4 '23
Dividends $19.3M
Buybacks $0.0M
Q1 '24
Dividends $3.0M
Buybacks $0.0M
Q2 '24
Dividends $3.0M
Buybacks $0.0M
Q3 '24
Dividends $3.0M
Buybacks $0.0M
Q4 '24
Dividends $3.0M
Buybacks $0.0M
Q1 '25
Dividends $3.0M
Buybacks $5.0M
Q2 '25
Dividends $3.0M
Buybacks $0.0M
Q3 '25
Dividends $3.0M
Buybacks $5.0M
Q4 '25
Dividends $2.9M
Buybacks $10.0M
Q1 '26
Dividends $2.9M
Buybacks $5.0M
Q2 '26
Dividends $2.9M
Buybacks $0.0M
Dividends
Buybacks
FY16
Diluted shares 0.06B
FY17
Diluted shares 0.05B
FY18
Diluted shares 0.06B
FY19
Diluted shares 0.06B
FY20
Diluted shares 0.05B
FY21
Diluted shares 0.05B
FY22
Diluted shares 0.05B
FY23
Diluted shares 0.05B
FY24
Diluted shares 0.05B
FY25
Diluted shares 0.05B
Balance sheet
Cash, debt and the ratios that show how comfortably Nu Skin Enterprises, Inc. can carry it.
FY16
Cash $368M
Debt $417M
FY17
Cash $438M
Debt $389M
FY18
Cash $398M
Debt $430M
FY19
Cash $344M
Debt $362M
FY20
Cash $424M
Debt $345M
FY21
Cash $355M
Debt $384M
FY22
Cash $279M
Debt $418M
FY23
Cash $268M
Debt $516M
FY24
Cash $198M
Debt $404M
FY25
Cash $240M
Debt $233M
Cash
Debt
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $355M | $279M | $268M | $198M | $240M |
| Debt incl. finance leases | $384M | $418M | $516M | $404M | $233M |
| Net debt / EBITDA | 0.1x | 0.8x | 2.1x | — | −0.1x |
| Debt / equity | 0.4x | 0.4x | 0.6x | 0.6x | 0.3x |
| Interest coverage | 21.3x | 8.2x | 1.9x | −5.7x | 4.7x |
| Current ratio | 1.6x | 2.1x | 2.1x | 1.8x | 2.1x |
| Quick ratio | 0.9x | 1.2x | 1.3x | 1.2x | 1.4x |
| Total assets | $1.9B | $1.8B | $1.8B | $1.5B | $1.4B |
| Total liabilities | $994M | $924M | $987M | $817M | $600M |
| Shareholders' equity | $913M | $897M | $822M | $651M | $805M |
| Net debt (− = net cash) | $28.7M | $139M | $248M | $206M | −$7.3M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ | ✕ | ✓ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | ✓ | ✕ | ✓ | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ |
| Current ratio rose | — | ✕ | ✓ | ✓ | ✕ | ✕ | ✓ | ✓ | ✕ | ✓ |
| Share count didn't rise | — | ✓ | ✕ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ |
| Gross margin rose | — | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ |
| Revenue rose relative to assets | — | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ | ✕ | ✓ | ✕ |
| F-score | — / 3 | 6 / 9 | 5 / 9 | 7 / 9 | 5 / 9 | 5 / 9 | 5 / 9 | 5 / 9 | 5 / 9 | 6 / 9 |
| Accruals ratio | −9.0% | −11.3% | −4.9% | −0.3% | −10.1% | 0.3% | −0.2% | −6.1% | −15.8% | 5.6% |
| Altman Z'' | 6.76 | 6.66 | 6.39 | 6.65 | 6.04 | 6.24 | 6.34 | 5.78 | 5.02 | 7.36 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $2.2B | $2.3B | $2.7B | $2.4B | $2.6B | $2.7B | $2.2B | $2.0B | $1.7B | $1.5B |
| Gross profit | $1.7B | $1.8B | $2.0B | $1.8B | $1.9B | $2.0B | $1.6B | $1.4B | $1.2B | $1.0B |
| Research and development | $24.3M | $22.0M | $23.0M | $30.1M | $23.3M | $27.2M | $23.3M | $22.6M | $13.0M | $10.8M |
| Operating income | $231M | $274M | $241M | $267M | $258M | $234M | $111M | $48.3M | −$152M | $65.8M |
| Interest expense | $15.6M | $22.2M | $21.8M | $19.2M | $13.1M | $11.0M | $13.5M | $25.6M | $26.4M | $13.9M |
| Pretax income | $213M | $266M | $220M | $255M | $256M | $232M | $89.0M | $26.6M | −$175M | $196M |
| Income tax | $69.8M | $136M | $97.8M | $81.6M | $64.9M | $85.2M | −$15.8M | $18.0M | −$28.5M | $36.0M |
| Net income | $143M | $129M | $122M | $174M | $191M | $147M | $105M | $8.6M | −$147M | $160M |
| Diluted EPS | $2.55 | $2.36 | $2.16 | $3.10 | $3.63 | $2.86 | $2.07 | $0.17 | −$2.95 | $3.18 |
| Diluted shares | 0.06B | 0.05B | 0.06B | 0.06B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B | 0.05B |
| Cash flow | ||||||||||
| Cash from operations | $275M | $303M | $203M | $178M | $379M | $142M | $108M | $119M | $112M | $80.3M |
| Capital expenditure | $50.2M | $60.2M | $70.4M | $66.1M | $63.8M | $68.6M | $59.1M | $58.5M | $41.6M | $34.3M |
| Free cash flow | $225M | $242M | $132M | $112M | $315M | $73.0M | $49.0M | $60.1M | $70.2M | $46.0M |
| Depreciation and amortization | $72.4M | $71.6M | $83.0M | $76.7M | $74.0M | $76.3M | $72.5M | $70.9M | $69.8M | $52.3M |
| Stock-based compensation | $8.9M | $19.3M | $26.6M | $9.9M | $24.1M | $23.2M | $12.4M | $15.6M | $14.8M | $24.1M |
| Acquisitions | — | $31.7M | $38.5M | $8.1M | $14.9M | $19.0M | $0.0M | $77.3M | $0.0M | $0.0M |
| Share buybacks | $247M | $71.7M | $69.6M | $0.8M | $144M | $80.4M | $70.0M | $13.0M | $0.0M | $20.0M |
| Dividends paid | $78.4M | $76.1M | $80.6M | $82.2M | $78.4M | $76.3M | $77.0M | $77.6M | $11.9M | $11.8M |
| Dividends and buybacks | $326M | $148M | $150M | $83.0M | $223M | $157M | $147M | $90.6M | $11.9M | $31.9M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $368M | $438M | $398M | $344M | $424M | $355M | $279M | $268M | $198M | $240M |
| Total debt | $417M | $389M | $430M | $362M | $335M | $376M | $402M | $503M | $394M | $224M |
| Finance lease liabilities | — | — | — | — | $9.7M | $7.3M | $15.5M | $12.7M | $10.2M | $8.4M |
| Current assets | $714M | $778M | $799M | $740M | $903M | $873M | $760M | $702M | $539M | $548M |
| Current liabilities | $399M | $447M | $440M | $357M | $543M | $530M | $359M | $329M | $297M | $264M |
| Inventory | $250M | $253M | $296M | $276M | $314M | $400M | $346M | $280M | $190M | $179M |
| Property and equipment, net | $445M | $465M | $465M | $454M | $468M | $454M | $445M | $433M | $380M | $377M |
| Goodwill | $115M | $115M | $197M | $197M | $203M | $206M | $206M | $218M | $83.6M | $83.6M |
| Intangible assets | $63.6M | $67.6M | $90.0M | $80.3M | $89.5M | $77.0M | $66.7M | $95.3M | $74.3M | $42.6M |
| Total assets | $1.5B | $1.6B | $1.7B | $1.8B | $2.0B | $1.9B | $1.8B | $1.8B | $1.5B | $1.4B |
| Total liabilities | $810M | $885M | $913M | $894M | $1.1B | $994M | $924M | $987M | $817M | $600M |
| Shareholders' equity | $664M | $705M | $782M | $875M | $894M | $913M | $897M | $822M | $651M | $805M |
| Margins | ||||||||||
| Gross margin | 77.3% | 78.0% | 76.3% | 76.0% | 74.5% | 75.0% | 71.7% | 68.9% | 68.2% | 69.4% |
| Operating margin | 10.5% | 12.0% | 9.0% | 11.0% | 10.0% | 8.7% | 5.0% | 2.5% | −8.8% | 4.4% |
| EBITDA margin | 13.7% | 15.2% | 12.1% | 14.2% | 12.8% | 11.5% | 8.2% | 6.1% | −4.7% | 7.9% |
| Net margin | 6.5% | 5.7% | 4.5% | 7.2% | 7.4% | 5.5% | 4.7% | 0.4% | −8.5% | 10.8% |
| FCF margin | 10.2% | 10.6% | 4.9% | 4.6% | 12.2% | 2.7% | 2.2% | 3.1% | 4.1% | 3.1% |
| Returns | ||||||||||
| Return on capital | 21.8% | 27.2% | 19.2% | 20.4% | 23.9% | 16.3% | 10.9% | 3.0% | −14.1% | 6.8% |
| Return on capital employed | 21.5% | 24.0% | 19.2% | 18.9% | 18.2% | 17.0% | 7.6% | 3.3% | −12.9% | 5.8% |
| Return on equity | 21.5% | 18.9% | 16.4% | 20.9% | 21.6% | 16.3% | 11.6% | 1.0% | −19.9% | 22.0% |
| Return on assets | 9.7% | 8.4% | 7.4% | 10.0% | 10.3% | 7.6% | 5.6% | 0.5% | −8.9% | 11.1% |
| Return on tangible equity | 29.5% | 24.8% | 24.6% | 29.0% | 31.8% | 23.4% | 16.8% | 1.7% | −29.7% | 23.6% |
| Growth | ||||||||||
| Revenue growth | — | 3.2% | 17.5% | −9.7% | 6.7% | 4.4% | −17.4% | −11.5% | −12.0% | −14.3% |
| Net income growth | — | −9.5% | −5.8% | 42.4% | 10.3% | −23.0% | −28.9% | −91.8% | −1,805.6% | — |
| EPS growth | — | −7.5% | −8.5% | 43.5% | 17.1% | −21.2% | −27.6% | −91.8% | −1,835.3% | — |
| FCF growth | — | 7.7% | −45.4% | −15.5% | 181.9% | −76.9% | −32.8% | 22.7% | 16.6% | −34.4% |
| Share count change | — | −2.2% | 3.0% | −1.0% | −5.7% | −2.5% | −1.8% | −1.3% | −0.4% | 1.3% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.2x | −0.1x | 0.1x | 0.1x | −0.2x | 0.1x | 0.8x | 2.1x | — | −0.1x |
| Debt / equity | 0.6x | 0.6x | 0.6x | 0.4x | 0.4x | 0.4x | 0.4x | 0.6x | 0.6x | 0.3x |
| Interest coverage | 14.8x | 12.4x | 11.0x | 13.9x | 19.7x | 21.3x | 8.2x | 1.9x | −5.7x | 4.7x |
| Current ratio | 1.8x | 1.7x | 1.8x | 2.1x | 1.7x | 1.6x | 2.1x | 2.1x | 1.8x | 2.1x |
| Quick ratio | 1.2x | 1.2x | 1.1x | 1.3x | 1.1x | 0.9x | 1.2x | 1.3x | 1.2x | 1.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.3% | 2.6% | 2.6% | 2.7% | 2.5% | 2.5% | 2.7% | 3.0% | 2.4% | 2.3% |
| Stock comp / revenue | 0.4% | 0.8% | 1.0% | 0.4% | 0.9% | 0.9% | 0.6% | 0.8% | 0.9% | 1.6% |
| Payouts / FCF | 144.7% | 61.0% | 113.4% | 74.2% | 70.6% | 214.7% | 300.1% | 150.7% | 17.0% | 69.3% |
| Quality scores | ||||||||||
| Piotroski F-score | — | 6.0 | 5.0 | 7.0 | 5.0 | 5.0 | 5.0 | 5.0 | 5.0 | 6.0 |
| Altman Z'' | 6.8 | 6.7 | 6.4 | 6.7 | 6.0 | 6.2 | 6.3 | 5.8 | 5.0 | 7.4 |
| Accruals ratio | −9.0% | −11.3% | −4.9% | −0.3% | −10.1% | 0.3% | −0.2% | −6.1% | −15.8% | 5.6% |
Source: SEC EDGAR XBRL filings (CIK 0001021561). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.